Podcasts about prophylactic

Prior to initiating the war of conquest of the land of Canaan, the nation did the prudent thing: they undertook a reconnaissance mission to scout out the enemy defenses. Moshe selected 12 righteous men, one from each tribe, to traverse the land and inspect it from the inside. The result was a catastrophic disaster: the […]

Prior to initiating the war of conquest of the land of Canaan, the nation did the prudent thing: they undertook a reconnaissance mission to scout out the enemy defenses. Moshe selected 12 righteous men, one from each tribe, to traverse the land and inspect it from the inside. The result was a catastrophic disaster: the scouts brought a devastating report about the land, prompting the people to lose faith in God and in the prospect of entering Canaan. In this Parsha podcast, we explore three elements of the Parsha: the first segment orients around one of the descriptions of the land offered by the scouts. The second and third segments relate to the end of the Parsha: The execution of a person who was gathering twigs on Shabbos, and the commandment to tie fringes to corners of our garments.– – – – – – – – – – – – – – – – – – – – – –DONATE: Please consider supporting the podcasts by making a donation to help fund our Jewish outreach and educational efforts at https://www.torchweb.org/support.php. Thank you!– – – – – – – – – – – – – – – – – – – – – –NEW TORCH Mailing Address POBox:TORCHPO BOX 310246HOUSTON, TX 77231-0246– – – – – – – – – – – – – – – – – – – – – –Email me with questions, comments, and feedback: rabbiwolbe@gmail.com– – – – – – – – – – – – – – – – – – – – – –SUBSCRIBE to my Newsletterrabbiwolbe.com/newsletter– – – – – – – – – – – – – – – – – – – – – –SUBSCRIBE to Rabbi Yaakov Wolbe's PodcastsThe Parsha PodcastThe Jewish History PodcastThe Mitzvah Podcast This Jewish LifeThe Ethics PodcastTORAH 101 ★ Support this podcast ★

Welcome to the Oncology Brothers podcast! In this episode, we dived deep into the world of bispecific antibodies approved for multiple myeloma. Joined by myeloma specialists Dr. Hamza Hashmi from Memorial Sloan Kettering and Dr. Cesar Rodriguez from Mount Sinai, they discussed the latest updates, clinical pearls, and practical insights for community oncologists. Listen us on: Spotify: https://open.spotify.com/show/31BXhY9FM4gPWG10WgE11o Apple Podcast: https://podcasts.apple.com/us/podcast/oncology-brothers-practice-changing-cancer-discussions/id1653340966 Follow us on social media: X/Twitter: https://twitter.com/oncbrothers ⁠Instagram: https://www.instagram.com/oncbrothers Website: https://oncbrothers.com/ Key topics included: Overview of bispecific antibodies, focusing on GPRC5D and BCMA-targeted therapies. Detailed discussion on talquetamab, teclistamab, elranatamab, and linvoseltamab, including dosing, side effects, and management strategies. Insights on managing cytokine release syndrome (CRS), neurotoxicity, and other side effects like dysgeusia, skin toxicity, and infections. Prophylactic measures, including the use of IVIG and tocilizumab, to enhance patient care and quality of life. Whether you're a healthcare professional or simply interested in the latest advancements in cancer treatment, this episode is packed with valuable information. Don't forget to like, subscribe, and check out our other episodes for more insights into oncology! #MultipleMyeloma, #BispecificAntibody, #ICANS, #CRSmanagement, #OncologyBrothers

In this episode, I dive into one of the most challenging decisions many cancer parents face—how to protect your child from infection without unintentionally causing further harm. We're talking about PJP (Pneumocystis jirovecii pneumonia) and the standard use of long-term prophylactic antibiotics during treatment. While the intention is to prevent a serious infection, I explore the growing concern that this approach may be compromising the very immune system it's meant to protect. Drawing from both research and my personal experience, I unpack what's often not discussed in the oncology setting and share a more supportive, integrative approach to protecting your child's health during treatment.   LINKS: Nebulizer Guide: https://www.seasonjohnson.com/how-to-use-a-nebulizer-to-improve-respiratory-health-detoxification/ Red Light Therapy Device (Code SEASONJOHNSON for $260 off): https://bit.ly/seasonjohnsonlume Join Thrive Through Cancer Community: https://biodynamicwellness.com/services   CONNECT WITH SEASON: Website: seasonjohnson.com Follow along on Instagram: @seasonjohnson  

Kevin, LJ, and Uncle Tony dive into the surprising Dexter Lawrence trade to the Bengals, debate whether Jeremiah Love is worth a top-10 pick, and somehow end up discussing emergency appendectomies in professional sports. Plus: insurance fraud involving bear costumes, a 40-year concert bootlegger's internet archive, and Kevin accidentally reveals he's only 75% sure we landed on the moon. The NFL Draft is in 48 (Editor's note: -15) hours - are you ready?See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Kristin Crowley has a family history of breast cancer, and a genetic test shows she's BRCA 2 positive. She shares her journey through surgery and the complicated decisions she is making as a middle aged woman who is high risk.

This week on the show Andrew and Ted discuss the Prime Video original "BALLSUP", starring Mark Wahlberg and Paul Walter Hauser. Prophylactic designer Elijah (Hauser) and the company's top salesman Brad (Wahlberg) team up to sell the Brazilian World Cup honchos on making their new condom the "official" condom of the World Cup. While in attendance at the World Cup, a drunk Elijah takes the fact that they lost the contract after they secured it personally when he thinks the competition mascot is mocking him during the game and subsequently charges the mascot on the pitch. Brad follows in an attempt to stop Elijah only to stop the game tying point from the Brazilian team, leaving Argentina the victor. Arrested and subsequently released the duo find themselves to be hunted by all of Brazil and ultimately end up in the compound of the countries leading drug cartel leader. Tune into find out what Andrew and Ted thought of this action / comedy.

In this episode of the NCS Podcast Hot Topics series, host Richard Choi, DO, FNCS, is joined by Wendy Ziai, MD, professor of neurology and critical care medicine at Johns Hopkins University, to discuss the article "Prophylactic Anti-Seizure Medication in Patients with Lobar Intracerebral Hemorrhage", recently published in Neurocritical Care. Their conversation explores the ongoing debate surrounding prophylactic antiseizure medication use in patients with lobar intracerebral hemorrhage. They review current guideline recommendations, highlight limitations in the existing evidence and consider the challenge of balancing seizure prevention with the risk of adverse effects. Dr. Ziai reviews key findings from prior trials as well as the featured study, which demonstrated lower rates of early seizures among patients who received prophylaxis. She also addresses questions related to patient selection, nonconvulsive status epilepticus and long-term cognitive outcomes. The discussion further considers the role of continuous EEG monitoring in the first 48 hours and how future study designs may help clarify which patients, if any, are most likely to benefit. The views expressed on the NCS Podcast are solely those of the hosts and guests and do not necessarily reflect the opinions or official positions of the Neurocritical Care Society. 

Send us Fan MailIn this Daily Journal Club episode, Ben and Daphna review a massive Swedish national cohort study from JAMA Network Open examining early prophylactic hydrocortisone in extremely preterm infants. They discuss the targeted regimens used, differences in gestational age outcomes, and whether a blanket prophylactic approach is truly effective for preventing BPD. With impressive data covering 98% of all NICU admissions in Sweden, the hosts debate the nuances of targeting 24 to 25-weekers versus older preemies and the potential confounding impact of chorioamnionitis. Tune in for your daily snack of evidence-based medicine and insights into optimizing NICU steroid protocols!----Early Prophylactic Hydrocortisone and Bronchopulmonary Dysplasia-Free Survival in Extremely Preterm Infants. Smedbäck V, Björklund LJ, Flisberg A, Wróblewska J, Baud O, Wejryd E, Ådén U.JAMA Netw Open. 2026 Feb 2;9(2):e2560146. doi:10.1001/jamanetworkopen.2025.60146.Support the showAs always, feel free to send us questions, comments, or suggestions to our email: nicupodcast@gmail.com. You can also contact the show through Instagram or Twitter, @nicupodcast. Or contact Ben and Daphna directly via their Twitter profiles: @drnicu and @doctordaphnamd. The papers discussed in today's episode are listed and timestamped on the webpage linked below.Enjoy!

Send a textIn this Journal Club episode, Ben and Daphna review the highly anticipated TREOCAPA trial results exploring the prophylactic use of acetaminophen for PDA closure in extremely preterm infants. They break down the study's tailored dosing regimens, safety outcomes like cholestasis, and discuss why achieving a higher rate of early ductal closure didn't necessarily translate to improved survival without severe morbidity. Plus, they share a nod to recent Neo Conference interviews and the realities of conducting clinical research in private practice. Tune in for a nuanced discussion on individualizing PDA management in the NICU!----Prophylactic Treatment of Patent Ductus Arteriosus With Acetaminophen: A Randomized Clinical Trial. Rozé JC, Cambonie G, Flamant C, Patkaï J, Mühlbacher T, Gascoin G, Rideau Batista Novais A, Tauzin M, Le Duc K, Beuchée A, Joye S, Babacheva E, Bouissou A, Ligi I, Tammela O, Plourde M, Dempsey E, Tosello B, Nguyen K, Vincent M, Andresson P, Binder C, Kruse C, Barcos Munoz F, Kuhn P, Proença E, Bartocci M, Kermorvant-Duchemin E, Nellis G, Lumia M, Giapros V, Rigo V, Sankilampi U, Mendes da Graça A, Rønnestad A, Soukka H, Mondì V, Aikio O, Torre-Monmany N, Rüegger C, Baud O, Zeitlin J, Morgan AS, Baruteau AE, Ancel PY, Carbajal R, Bouazza N, Diallo A, Levoyer L, Kemper R, Hallman M, Alberti C, Ursino M; TREOCAPA Study Group.JAMA Pediatr. 2026 Feb 16:e256150. doi: 10.1001/jamapediatrics.2025.6150. Online ahead of print.PMID: 41697673Support the showAs always, feel free to send us questions, comments, or suggestions to our email: nicupodcast@gmail.com. You can also contact the show through Instagram or Twitter, @nicupodcast. Or contact Ben and Daphna directly via their Twitter profiles: @drnicu and @doctordaphnamd. The papers discussed in today's episode are listed and timestamped on the webpage linked below. Enjoy!

Description:  In this episode of the SMFM Podcast, we continue our American Heart Month series highlighting Patient Safety and Quality (PSQI) tools designed to improve cardiovascular outcomes in pregnancy. Dr. Melissa Spiel is joined by Dr. Andy Combs and Dr. Jamie Morgan to discuss the updated 2026 SMFM Checklist for Preeclampsia Risk-Factor Screening to Guide Recommendations for Prophylactic Low-Dose Aspirin. The conversation reviews key updates to the USPSTF recommendations, how the checklist supports systematic identification of eligible patients, and practical strategies for implementation in diverse practice settings. The episode also explores the companion process-based quality metric aimed at improving aspirin initiation by 16 weeks and helping practices measure adherence and equity in care. Resources:  Society for Maternal-Fetal Medicine Special Statement: Updated checklists for preeclampsia risk-factor screening to guide recommendations for prophylactic low-dose aspirin - SMFM Publications and Clinical Guidelines Society for Maternal Fetal-Medicine Special Statement: Prophylactic low-dose aspirin for preeclampsia prevention—quality metric and opportunities for quality improvement - SMFM Publications and Clinical Guidelines Disclaimer: "The Public Health System Components: Clinicians who are related to Maternal-Fetal Medicine program is supported by the Centers for Disease Control and Prevention of the U.S. Department of Health and Human Services (HHS) as part of a financial assistance award to the Society for Maternal-Fetal Medicine (SMFM) totaling $1,278,000 with 100 percent funded by CDC/HHS. The contents are those of the authors and do not necessarily represent the official views of nor endorsement, by CDC/HHS or the U.S. Government."

Facing a genetic mutation that significantly increases the risk of breast cancer means making decisions that truly feel life‑defining. Today's guest on the DiepCJourney® podcast, Emily Koellner, knows this experience intimately. With a strong family history of cancer, a mutation inherited from her father's side, and the unwavering support of her two sisters and loved ones, Emily navigated her choices with courage and clarity. Many of you will remember my earlier interview with her sisters about their own prophylactic DIEP flap journeys. Now it's Emily's turn to share her perspective, her strength, and the path she chose. We begin with a recap of her decision to have reconstructive surgery. Emily shares valuable information with our listeners about surveillance vs. the decision to have prophylactic reconstructive surgery to reduce her risk of getting breast cancer. We recall the two stories Emily wrote for the DiepCJourney® blog about her decision to have a child after her DIEP flap and the planning and discussion she had with Dr. Ledoux, her surgeon at PRMA about this decision. You can read Part 1 here: Patience and Persistence: Pregnancy Post-DIEP Read Part 2 here: Wonder and Happiness: pregnancy Post-DIEP One of the most poignant statements from one of these blog posts from Emily is: "I'm celebrating the proactive decision I made to take my health and future into my own hands." She continues to be a strong advocate in the community and shares a very recent encounter with another patient who reached out to her in a message on social media asking about having a child after DIEP flap. You won't want to miss what she shares. Emily continued her risk reducing surgeries by having a robotic assisted salpingo-oophorectomy at the request of her gynecological oncologist. She tells us about her recovery and how she is doing now. Be sure to listen to the podcast with Emily and her sisters Elaine and Eleanor: Episode 38: Sisters, BRCA 1, Three DIEP flap Stories Connect with Emily on the following platforms: Instagram: https://www.instagram.com/emilymkoellner/ Facebook: https://www.facebook.com/emkoellner LinkedIn: https://www.linkedin.com/in/emilykoellner/

Have you ever felt like you were "waiting for the inevitable" because of your family history? In today's episode, Dr. Jen dives deep into the complex world of preventative mastectomies and elective hysterectomies. While conventional medicine often views these procedures as the only solution for high-risk genetic markers like BRCA1 and BRCA2, Dr. Jen explores the vital "middle ground." We discusses the limitations of standard screenings, the energetic significance of our feminine centers, and how epigenetics—the way we live, eat, and supplement—can influence how our genes actually express themselves. This isn't just about surgery; it's about understanding the "Root Cause" of why our bodies create dense tissue or fibroids in the first place. Themes: Understanding that while we may carry certain genes, our environment and hormonal balance (especially the role of progesterone) act as the "software" that runs the system. Why traditional mammography isn't a one-size-fits-all solution for dense tissue and the benefits of radiation-free options like thermography. Honoring the energetic "portals" of the breasts and womb, and how to maintain that feminine vitality even if physical organs are removed. Why hormonal replacement is a non-negotiable for long-term bone, brain, and heart health following a hysterectomy. Utilizing peptides and targeted lifestyle shifts to address inflammation and tissue health before a crisis occurs. Connect with Jen: 

This week, Aebhric O'Kelly, Bill Vasios, and Rhod Jordan will host an open discussion on managing austere burn patients, covering airway management, fluid resuscitation, infection control, and pain management. The speakers emphasise the complexity of burn cases and the importance of accurate assessment and treatment protocols. They also highlight the need for effective communication and patient involvement in care, as well as the use of innovative techniques like topical morphine for pain management.TakeawaysBurns are incredibly complicated, but they're complex patients.Managing an individual patient's airway has to be factored in.You want to protect and secure the airway and avoid obstructions.The goal is to achieve maximal accuracy in fluid resuscitation.You can infuse that fluid rectally if you don't have IV fluids.Prophylactic antibiotics are not indicated in burn patients.Topical morphine works really, really well for pain management.Involving the patient in their care has a positive effect.Infection control is the means of preventing infection.Burn management is more art than science.Chapters00:00 Introduction to Burns Management03:08 Airway Management in Burn Patients05:52 Assessing Burn Size and Fluid Resuscitation09:00 Fluid Administration Techniques11:38 Oral vs IV Resuscitation14:53 Monitoring and Adjusting Treatment17:36 Dynamic Management of Burn Patients25:18 Vital Signs Monitoring in Critical Care28:01 Continuous Assessment and Patient Management32:07 Patient Involvement in Vital Signs Monitoring35:10 Urine Output and Fluid Resuscitation41:33 Infection Control in Burn Management48:20 Pain Management Strategies in Burns

 Merry Christmas! This month for the December 2025 episode of the RCEM Learning Podcast Andy and Dave are talking about higher MAP targets in sepsis and the routine use of antibiotics for max-fax fractures. Rob attempts a festive round up of the most impactful guidelines of the year. We'll then end with New Online. If you'd like to email us, please feel free to do so here. After listening, complete a short quiz to have your time accredited for CPD at the RCEMLearning website! (03:19) New in EM - Higher MAP targets in Sepsis Efficacy of targeting high mean arterial pressure for older patients with septic shock (OPTPRESS): a multicentre, pragmatic, open-label, randomised controlled trial (Endo et al., 2025) (15:19) Most Impactful Guidelines of the Year European Resucitation Guidelines - Guidelines on Cardiopulmonary Resuscitation (ERC, 2025) NHS England - Urgent and emergency care plan 2025/26 (NHS England, 2025) NHS England - Guidance to support the commissioning and delivery of ambulance services in 2025/26(NHS England, 2025) NICE - NG246 Overweight and obesity management (NICE, 2025) NICE - NG253 - Suspected sepsis in people aged 16 or over: recognition, assessment and early management (NICE, 2025) NICE - NG254 - Suspected sepsis in under 16s: recognition, diagnosis and early management (NICE, 2025) NICE - NG255 - Suspected sepsis in pregnant or recently pregnant people: recognition, diagnosis and early management (NICE, 2025) RCPCH - Facing the Future - standards for children and young people in emergency care settings (RCPCH, 2025) RCEM - GPEMS(RCEM, 2025) (38:07) New in EM - Routine use of antibiotics in facial fractures Prophylactic antibiotic use in trauma patients with non-operative facial fractures: A prospective AAST multicenter trial (Mian et al., 2025) (47:10) New Online – new articles on RCEMLearning for your CPD Is Normalisation of Deviance the "Standard" in Medicine? - Neel Bhandani Mental Illness in Children by Jidhin Davis Rest, sleep, and our breaks - the conversation we cant tire of - Amar Mashru

Send us a textDr. Edgardo Szyld from Indiana University presents the PLANT study evaluating 20 minutes of prophylactic CPAP for late preterm infants (34-36+6 weeks) born via cesarean section. This population represents 70% of US preterm births and experiences five times higher respiratory distress rates with cesarean delivery. The pragmatic pilot enrolled 100 patients, demonstrating reduced NICU admissions without pneumothorax cases—addressing previous safety concerns from observational data. Szyld's team is planning PLANT 2, targeting 35-36 weekers across 11 international centers, which will compare outcomes with and without antenatal steroids. This pragmatic approach addresses a high-volume but understudied population significantly impacting NICU resources. Support the showAs always, feel free to send us questions, comments, or suggestions to our email: nicupodcast@gmail.com. You can also contact the show through Instagram or Twitter, @nicupodcast. Or contact Ben and Daphna directly via their Twitter profiles: @drnicu and @doctordaphnamd. The papers discussed in today's episode are listed and timestamped on the webpage linked below. Enjoy!

In this episode of the PFC Podcast, Dr. Van Wyk discusses the latest updates in traumatic brain injury (TBI) management, focusing on insights from the CRASH-3 trial, the use of TXA, hypertonic saline, and sodium bicarbonate. He emphasizes the importance of monitoring intracranial pressure and the potential for surgical interventions in austere environments. The conversation also touches on the controversial topic of seizure prophylaxis and end-of-life considerations in TBI care.TakeawaysDr. Van Wyk is a neurologist with extensive experience in TBI management.The CRASH-3 trial provides insights into TXA's effectiveness in TBI patients.Moderate TBI patients may benefit more from TXA than severe cases.Dosing protocols for TXA are still under discussion, with traditional methods being preferred.Hypertonic saline is recommended for TBI management, but higher concentrations may be beneficial.Sodium bicarbonate can be an effective alternative for managing ICP.Prophylactic use of hypertonic saline is debated but may be reasonable in certain cases.Seizure prophylaxis is not universally recommended but can prevent complications in TBI patients.Monitoring ICP through optic nerve sheath diameter is evolving, with trends being more useful than absolute values.Surgical interventions for TBI may be necessary in austere environments, but should be approached with caution.Chapters00:00 Introduction to Traumatic Brain Injury Management02:00 Insights from the CRASH-3 Trial06:43 Dosing Protocols for TXA in TBI11:28 Hypertonic Saline: Concentration and Administration17:21 Alternative Treatments for Increased ICP22:58 Prophylactic Sodium Management in TBI25:17 Seizure Prophylaxis in Traumatic Brain Injury30:04 Monitoring Intracranial Pressure Non-Invasively35:17 Surgical Interventions for Elevated ICP42:10 End-of-Life Decisions in Severe TBIFor more content, go to ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠www.prolongedfieldcare.org⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Consider supporting us: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠patreon.com/ProlongedFieldCareCollective⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ or ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠www.lobocoffeeco.com/product-page/prolonged-field-care⁠

Stacy Martin says genetic testing saved her life.   The testing indicated she had the CDH1 mutation.  The mutation gave her an 80 percent chance of getting gastric cancer and a 60 percent chance of breast cancer.  She opted for a prophylactic total gastrectomy to remove her stomach and addressed the possibility of breast cancer with a bilateral mastectomy.  Without a stomach, Stacy has had to change the way she eats, requiring food every two hours, and having to completely chew everything she eats.  Despite this live-changing surgery, Stacy is leading a healthy and happy life.   Unlike most people with cancer, Stacy's diagnosis was not preceded by symptoms.  Her mother had already been diagnosed with Stage IV uterin cancer.  That prompted Stacy and her siblings to undergo a genetic panel test.  It revealed Stacy had the CDH1 mutation, which meant she an 80 percent chance of getting gastric cancer and a 60 percent chance of breast cancer.    She had three options but chose to be proactive with a prophylactic total gastrectomy in 2019, a procedure that removed her stomach.  It was after the surgery that pathology revealed Stacy had gastric cancer in her removed stomach.    After successfully addressing the possibility of stomach cancer, she did the same with breast cancer with a bilateral mastectomy in 2020.   Stacy Martin said the toughest part of her cancer experience wasn't the treatment, but what she dealt with upon its completion.  She said she had to learn how to eat, and that without a stomach, she had to eat every two hours.  While she took snacks with her wherever she went, she had to alternate between snacks and something more substantial, making sure she got enough protein and carbohydrates.  Anything she ate had to be completely chewed because she no longer had the gastric juices in her stomach that break down food.  The only thing she can't eat are raw oysters because she says they are impossible to chew.   Stacy says genetic testing saved her life but admits it is not for everybody because the decision to go forth with such testing is a deeply personal decision because some people don't want to know what the tests could reveal. Despite her cancer journey, Stacy lives a happy life.  She resumed her passion of hiking near her home in Chattanooga, Tennessee, and consumption of nuts resulted in her establishing Seahorse Snacks, which she operates out of her home.   Additional Resources:   Seahorse Snacks: https://www.seahorsesnacks.com   No Stomach For Cancer: https://www.nostomachforcancer.org          

Send us a textWelcome back Rounds Table Listeners! We are back today with a Classic Rapid Fire episode. This week, Drs. Mike and John Fralick discuss two recent papers: the effects of spironolactone on heart failure and cardiovascular death in patients undergoing maintenance dialysis, and antibiotic prophylaxis in patients with cirrhosis and upper gastrointestinal bleeding. Two papers, here we go!Spironolactone versus placebo in patients undergoing maintenance dialysis (ACHIEVE): an international, parallel-group, randomised controlled trial (0:00 – 7:19)Prophylactic Antibiotics for Upper Gastrointestinal Bleeding in Patients With Cirrhosis: A Systematic Review and Bayesian Meta-Analysis (7:20 – 15:08)And for the Good Stuff (15:09 – 17:51):The $500m slugger who helped Canada get to the World SeriesClinical practice guidelines one-pagers coming soon to Trial Files: https://trialfiles.substack.com/Questions? Comments? Feedback? We'd love to hear from you! @roundstable @InternAtWork @MedicinePods

Are Some Folks using their Partner as an Intimate Prophylactic? A fascinating deep dive into the idea of the disposable soul mate?

Are Some Folks using their Partner as an Intimate Prophylactic? A fascinating deep dive into the idea of the disposable soul mate?

Alice Ann Dodge met breast cancer head-on—caring for family, making tough choices, and giving back as a veterinarian and board member at The Rose. During this episode, you’ll hear Alice Ann’s story of: Growing up surrounded by breast cancer Choosing a preventive bilateral mastectomy in her twenties Turning support for others into her mission Key Questions Answered 1. What is the current gender breakdown in the veterinary profession, and why has it shifted? 2. What type of veterinary practice does Alice Ann Dodge specialize in? 3. How did breast cancer affect Alice Ann’s family? 4. How young was Alice Ann’s sister when she was diagnosed with breast cancer, and how did that influence Alice Ann’s choices? 5. What led Alice Ann to choose a bilateral mastectomy, and how did it change her life? 6. What were the attitudes and medical recommendations about genetic testing and preventative surgery 20 years ago? 7. What barriers and support systems did Alice Ann and her sister encounter during their breast cancer experiences? 8. How did Alice Ann’s experiences with breast cancer inform her work on The Rose’s board? 9. Does Alice Ann counsel young women regarding breast cancer risk? 10. What are Alice Ann’s thoughts on loss and grief, both as a veterinarian and in her personal life? 11. How does Alice Ann approach end-of-life care for animals and their humans? Timestamped Overview 00:00 Rethinking Career Paths 05:39 Sister's Cancer Diagnosis Impact 07:10 "Younger Cancer Patients: No Progress" 11:54 "Reflecting on Mystical Sisterhood" 13:59 "Peace After Surgery Fears" 17:26 Greatest Achievement: Life-Changing Surgery 22:19 "The Rose's Local Impact" 27:12 Life as a Veterinarian 29:33 Veterinary Heartbreaks and Challenges Support The Rose HERE. Subscribe to Let’s Talk About Your Breasts on Apple Podcasts, Spotify, iHeart, and wherever you get your podcasts.See omnystudio.com/listener for privacy information.

Darshan H. Brahmbhatt, Podcast Editor of JACC: Advances, discusses a recently published original research paper on Prophylactic VA-ECMO During Complex High-Risk PCI: A Randomized Controlled Trial.

Send us a textOvarian cancer, the second most common gynecologic malignancy, can be cured 90-95% of the time when caught early. Speaking of Women's Health Podcast Host talks through the risk factors like family history, BRCA gene mutations, obesity, and personal reproductive factors that are essential for early detection and prevention.• Risk increases with age (over 50), family history, and BRCA gene mutations• BRCA1 carriers face 35-70% lifetime risk compared to less than 2% in general population• Pregnancy, breastfeeding, and hormonal contraceptives reduce risk by decreasing ovulation• Tubal ligation, especially salpingectomy, dramatically lowers ovarian cancer risk• Common symptoms include abdominal swelling, urinary changes, bloating, early satiety• Regular pelvic exams and prompt reporting of symptoms are crucial for early detection• Ashkenazi Jewish women have ten times higher rate of BRCA mutations• Avoid using talcum powder near genital area as it's been linked to increased risk• Consider genetic counseling if strong family history exists• Prophylactic removal of tubes/ovaries after age 40 may be recommended for high-risk womenPlease follow the Speaking of Women's Health podcast wherever you listen to podcasts. Remember Be Strong, Be Healthy, and Be in Charge!Support the show

Manuscript Link:https://pubmed.ncbi.nlm.nih.gov/39153715/

Interview with Connor Prosty, MD, author of Prophylactic Antibiotics for Upper Gastrointestinal Bleeding in Patients With Cirrhosis: A Systematic Review and Bayesian Meta-Analysis, and Catherine Mezzacappa, MD, MPH, author of Antibiotic Prophylaxis in Variceal Hemorrhage—Time to Stop? Hosted by Ilana Richman, MD. Related Content: Prophylactic Antibiotics for Upper Gastrointestinal Bleeding in Patients With Cirrhosis Antibiotic Prophylaxis in Variceal Hemorrhage—Time to Stop?

Interview with Connor Prosty, MD, author of Prophylactic Antibiotics for Upper Gastrointestinal Bleeding in Patients With Cirrhosis: A Systematic Review and Bayesian Meta-Analysis, and Catherine Mezzacappa, MD, MPH, author of Antibiotic Prophylaxis in Variceal Hemorrhage—Time to Stop? Hosted by Ilana Richman, MD. Related Content: Prophylactic Antibiotics for Upper Gastrointestinal Bleeding in Patients With Cirrhosis Antibiotic Prophylaxis in Variceal Hemorrhage—Time to Stop?

CME credits: 1.00 Valid until: 11-08-2026 Claim your CME credit at https://reachmd.com/programs/cme/program-name/35992/ Hereditary angioedema (HAE) is a rare, potentially life-threatening genetic disorder characterized by recurrent episodic swelling of the skin, gastrointestinal tract, and airways. The core approach to treating HAE prioritizes the availability of effective on-demand acute therapy, early treatment to prevent attack progression, treatment of attacks, and long-term prophylaxis. Early treatment of all breakthrough attacks, regardless of severity and site, is critical to maximize efficacy and reduce morbidity and mortality. Ongoing management of HAE should include evaluation of breakthrough attacks and any concerns with the disease course and current therapy to decide if a therapy adjustment is warranted. In this educational series, expert faculty discuss the importance of early treatment and personalizing therapy, best practice for managing breakthrough attacks, and current and emerging therapies for HAE.

CME credits: 1.00 Valid until: 11-08-2026 Claim your CME credit at https://reachmd.com/programs/cme/program-name/35992/ Hereditary angioedema (HAE) is a rare, potentially life-threatening genetic disorder characterized by recurrent episodic swelling of the skin, gastrointestinal tract, and airways. The core approach to treating HAE prioritizes the availability of effective on-demand acute therapy, early treatment to prevent attack progression, treatment of attacks, and long-term prophylaxis. Early treatment of all breakthrough attacks, regardless of severity and site, is critical to maximize efficacy and reduce morbidity and mortality. Ongoing management of HAE should include evaluation of breakthrough attacks and any concerns with the disease course and current therapy to decide if a therapy adjustment is warranted. In this educational series, expert faculty discuss the importance of early treatment and personalizing therapy, best practice for managing breakthrough attacks, and current and emerging therapies for HAE.

Wound Care Nurse Consultant, Sue Creehan, MSN, RN, CWON, discusses best practices for using prophylactic dressing, types of multilayer foam dressings, and more.This episode is sponsored by Smith+Nephew.

Send us a textProphylactic hydrocortisone and the risk of sepsis in neonates born extremely preterm.Baud O, Lehert P; PREMILOC study group.Eur J Pediatr. 2025 Jun 14;184(7):419. doi: 10.1007/s00431-025-06248-9.PMID: 40515786 Clinical Trial.As always, feel free to send us questions, comments, or suggestions to our email: nicupodcast@gmail.com. You can also contact the show through Instagram or Twitter, @nicupodcast. Or contact Ben and Daphna directly via their Twitter profiles: @drnicu and @doctordaphnamd. The papers discussed in today's episode are listed and timestamped on the webpage linked below. Enjoy!

Homeoprophylaxis: Natural Immunity Through Homeopathy with Dr. Cathy May Lemmon  In this powerful episode of the Homeopathy Health Show, we're joined by Dr. Cathy May Lemmon—a global leader in homeopathy and founder of Homeoprophylaxis: A Worldwide Choice. She shares her inspiring journey and deep insights into how homeopathy can safely and naturally reduce disease susceptibility—for both people and animals. From Hahnemann's historic use of Belladonna in 1799 to modern-day nosodes, Dr. Cathy breaks down: ✅ The principles of homeoprophylaxis ✅ Its powerful use in children's health ✅ Why real healing goes beyond theory  

In this episode of the PFC Podcast, host Dennis engages with Andy Fisher to discuss the controversial topic of needle decompression in Individual First Aid Kits (IFACs). They explore the historical context of IFAC contents, the effectiveness of needle decompression, and the challenges in identifying tension pneumothorax in the pre-hospital setting. The conversation also delves into the training and decision-making processes in combat medicine, assessment techniques for pneumothorax, and potential alternatives to needle decompression. In this conversation, the speakers delve into the evolving perspectives on thoracostomy and its application in pre-hospital settings, particularly in combat medicine. They discuss the implications of tension physiology in hemothorax and the prevalence of massive hemothorax in recent years. The conversation also revisits treatment protocols for chest injuries, emphasizing the need for a shift towards simple thoracostomy over needle decompression. Finally, they evaluate the use of pigtail catheters versus traditional chest tubes, weighing the pros and cons of each in emergency situations.TakeawaysNeedle decompression is debated in the context of IFACs.Historical context shows that needle decompression was not originally included in official DOD lists.Hemorrhage is the leading cause of mortality in trauma cases.Tension pneumothorax is rare, occurring in only 1.1% of cases.Identifying tension pneumothorax in pre-hospital settings is challenging.Medics should rely on objective data for decision-making.Training often prioritizes speed over thorough assessment.Prophylactic interventions for tension pneumothorax may not be effective.Chest tubes are not always life-saving interventions.Exploring alternatives like finger thoracostomy may be beneficial. Evolving views on thoracostomy emphasize its selective use.Needle decompression may be overused in practice.Tension physiology can occur with blood accumulation in the chest.Massive hemothorax is increasingly recognized in trauma cases.Up to 49% of combat casualties require chest tubes.Simple thoracostomy should be prioritized over needle decompression.Patient monitoring is crucial in pre-hospital settings.Pigtail catheters may not be suitable for pre-hospital use.Chest tubes are preferred for their reliability in emergencies.Comfort for the patient is important but should not compromise urgent care.Chapters00:00 Introduction to the Podcast and Guest01:01 Debate on Needle Decompression in IFACs03:20 Historical Context of IFAC Contents06:40 Effectiveness of Needle Decompression09:09 Challenges in Identifying Tension Pneumothorax12:00 Training and Decision-Making in Combat Medicine16:21 Assessment Techniques for Pneumothorax21:29 Interventions for Tension Pneumothorax25:19 Exploring Alternatives to Needle Decompression25:50 Evolving Perspectives on Thoracostomy31:38 Understanding Tension Physiology in Hemothorax36:41 Revisiting Treatment Protocols for Chest Injuries43:12 Evaluating Pigtail Catheters vs. Chest TubesThank you to Delta Development Team for in part, sponsoring this podcast.⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠deltadevteam.com⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠For more content, go to ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠www.prolongedfieldcare.org⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Consider supporting us: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠patreon.com/ProlongedFieldCareCollective⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ or ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠www.lobocoffeeco.com/product-page/prolonged-field-care⁠⁠⁠

Send us a Text Message (please include your email so we can respond!)Episode 66! Today we talk about Acute Chest Syndrome in Sickle Cell Disease with one of our favorite hematologists, Benjamin Tillman! We base our discussion around the TASC trial or "Comparison of Prophylactic and Therapeutic Doses of Anticoagulation for Acute Chest Syndrome in Sickle Cell Disease" published by Dessap et al in AJRCCM April of 2025.Pubmed: https://pubmed.ncbi.nlm.nih.gov/40209087/AJRCCM: https://www.atsjournals.org/doi/10.1164/rccm.202409-1727OCIf you enjoy the show be sure to like and subscribe, leave that 5 star review! Be sure to follow us on the social @icucast for the associated figures, comments, and other content not available in the audio format! Email us at icuedandtoddcast@gmail.com with any questions or suggestions! Thank you Mike Gannon for the intro and exit music!

At the end of April 2025, we released an episode summarizing the ERAS update for 2025. In that episode/update, we summarized the data on extended spectrum prophylactic antibiotics at cesarean section in patients living with obesity. The ERAS protocol recognized the value of oral cephalexin and metronidazole for 48 hours in patients with obesity who receive single agent Cephalosporin prophylaxis preop. Now, a new (RCT) publication soon to be released in the Green Journal, evaluates whether using dual agent pre-op prophylaxis (ancef and zithromax) together with post op oral cephalexin and metronidazole has benefit in reduction of SSI composite risk. Does this help? When is too much prophylactic antibiotics, just too much? Listen in for details.

Antibody-drug conjugates (ADCs) are novel therapeutic agents designed to target specific tumor markers with potent anticancer drugs. The Association of Cancer Care Centers (ACCC) is dedicated to providing up-to-date information on ADC treatment management. In this episode, CANCER BUZZ speaks with Nancy Mallett, a patient advocate, to discuss the patient's perspective and experience receiving treatment for gynecologic cancers, particularly with ADCs such as mirvetuximab soravtansine-gynx. “[Providers] giving me the information and allowing us to decide together, instead of just telling me, makes me feel more cared about and that I'm not just a number, I'm a person. They care about what I think, and look at my life and what it can do for me.” – Nancy Mallett   Nancy Mallett Patient Advocate   Resources:  FDA Approval Summary: Mirvetuximab soravtansine-gynx for FRα-positive, Platinum-Resistant Ovarian Cancer - https://bit.ly/4is00nD  Society of Gynecologic Oncology (SGO): Gynecologic Cancer Resources for Patients and Their Families - https://bit.ly/4jpYaoP  ASCO: Antibody-Drug Conjugates in Gynecologic Cancer - https://bit.ly/42GP5k8  Society of Gynecologic Oncology Journal Club: The ABCs of ADCs (Antibody drug Conjugates) - https://bit.ly/42U2962  Antibody-Drug Conjugates in Gynecologic Cancers - https://bit.ly/4cLYECZ    Funder Statement  This program is supported by AbbVie.   

Bryan and Peter are back together and they cover all of their favorite topics from selling vintage toys to traveling in Japan to old sneakers. They also get a VOICE MEMO from James McCabe who is nearing the end of his training for the Boston Marathon, but needs new motivation. And then Bryan and Peter finally make some decisions about making decisions about the big run on June 21st. 

Lisa Noghuchi of Jhpeigo (Johns Hopkins University) and Nyaradzo Mgodi (University of Zimbabwe) join Peter Hayward to discuss the MTN-043 study assessing safety and drug exposure of the dapivirine ring in breastfeeding women.Read the full article:https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(24)00306-0?dgcid=buzzsprout_icw_podcast_generic_lanhivContinue this conversation on social!Follow us today at...https://twitter.com/thelancethttps://instagram.com/thelancetgrouphttps://facebook.com/thelancetmedicaljournalhttps://linkedIn.com/company/the-lancethttps://youtube.com/thelancettv

Editor’s Choice: Primary prevention of post-molar gestational trophoblastic neoplasia in high-risk complete hydatidiform mole: A single-dose prophylactic actinomycin D, associated with uterine evacuation - a long retrospective cohort study Editorial: Prevention of Gestational Trophoblastic Neoplasia with Actinomycin -D at the time of evacuation: A Matter of Routine Practice or Reserve for Special Circumstances?

Dreams of Consciousness Podcast Episode 361 features an interview with Alexander Jones of Undeath. My thanks again to Alexander for speaking with me, and to you for listening. Music In This Episode: "Rise from the Grave" taken from the album It's Time...To Rise From the Grave "Lord Of The Grave" taken from the album Lesions Of A Different Kind "Cramped Caskets (Necrology)" "Disattachment of a Prophylactic in the Brain" taken from the album More Insane Thanks for listening! I hope you enjoyed listening to this as much as I enjoyed making it! Interviews, reviews, and more at www.dreamsofconsciousness.com

TIL that 4 AM is way too goddamn early to record a podcast. Apologies if I'm more chipper than usual, that's probably the coffee talking. Had some great e-mails this show. You should keep the streak alive and mouth off with your fingers at podcast@searls.co. Savor this version, folks. Gonna be at least a few weeks until you'll have another one. International Driver's Permit Don't be that guy. Don't drive a go-kart in downtown Tokyo Watch my final talk, The Empowered Programmer (Justin's Version) I have to pay for a search engine now, wtf macOS Sequoia iPhone Mirroring is cool Aaron's puns, ranked The Nintendo Music app is rad Fresca is extremely-flavored seltzer water Don't disable "Prioritize Faster Shooting" Google has a thumb on the scale Apple is buying Pixelmator Mass Effect is coming to Amazon Prime Video Pour one out for the You've Got Mail guy Notepad.exe is AI now LLMs may be reaching a point of diminishing returns Newest member of the badass scientist of the month club How to undervolt your GPU Like a Dragon: Yakuza Galileo G8 controller

Researchers Look at Prophylactic Antibiotics for the Prevention of Prosthetic Joint Infections By Spring Hatfield, RDH, BSPH Original article published on Today's RDH: https://www.todaysrdh.com/researchers-look-at-prophylactic-antibiotics-for-the-prevention-of-prosthetic-joint-infections/ Need CE? Start earning CE credits today at ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://rdh.tv/ce⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Get daily dental hygiene articles at ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.todaysrdh.com⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Follow Today's RDH on Facebook: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.facebook.com/TodaysRDH/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Follow Kara RDH on Facebook: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.facebook.com/DentalHygieneKaraRDH/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Follow Kara RDH on Instagram: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.instagram.com/kara_rdh/⁠⁠⁠⁠⁠⁠⁠

Linda Petticrew's battle with breast cancer at 34, and her daughter Rachel Evans' decision to have a prophylactic mastectomy at 25, reveal a narrative of resilience and proactive health decisions. Diagnosed with the BRCA1 gene, Rachel chose surgery as a precaution, influenced by her mother's experience with the disease. Their story highlights the importance of genetic testing and the strength found in family support. Key Questions Answered What is the relationship between Linda Petticrew and Rachel Evans? Linda underwent mastectomies due to being diagnosed with breast cancer, while Rachel had a prophylactic mastectomy due to testing positive for the BRCA1 gene. At what ages were Linda and Rachel when they had their mastectomies? Did anyone else in Linda's family have breast cancer prior to her diagnosis? How did Linda feel when she found out Rachel tested positive for the BRCA gene? How did the recovery experiences differ between Linda and Rachel? How did Rachel share her decision to undergo a prophylactic mastectomy and its implications? Timestamped Overview 00:00 Mother and daughter discuss their mastectomies experiences.05:16 Grateful for urging timely, crucial conversation, answers.08:32 Thankful for company benefits during hospital stay.11:32 Posted about BRCA gene on Instagram: questions followed.15:26 Shell supportive during cancer, knee replacement recovery.19:18 Mobile services provided for convenient health testing.21:40 Executive assistants supporting education, philanthropy in Houston.26:44 Podcast about breast health by The Rose. Support The Rose HERE. Subscribe to Let's Talk About Your Breasts on Apple Podcasts, Spotify, iHeart, and wherever you get your podcasts.See omnystudio.com/listener for privacy information.

TWiV reviews Marburg virus outbreak in Rwanda, cryo-EM based discovery of a parvovirus causing black wasting disease in farmed beetles, and a mosaic nanoparticle experimental vaccine that elicits cross-reactive sarbecovirus responses in pre-vaccinated animals. Hosts: Vincent Racaniello, Alan Dove, and Brianne Barker Subscribe (free): Apple Podcasts, Google Podcasts, RSS, email Become a patron of TWiV! Links for this episode MicrobeTV Discord Server Marburg virus disease, Rwanda (WHO) Suspected German Marburg case tests negative (Politico) Cryo-EM discovery of insect parvovirus (Cell) Mosaic sarbecovirus nanoparticle experimental vaccine (Cell) Letters read on TWiV 1157 Timestamps by Jolene. Thanks! Weekly Picks Brianne – ASM Lesson Plans Alan – A City on Mars, and this blog by a ham radio operator hit by Hurricane Helene Vincent – How to Win A Nobel Prize Listener Pick Laura – Science of Public Communication (original article) Intro music is by Ronald Jenkees Send your virology questions and comments to twiv@microbe.tv Content in this podcast should not be construed as medical advice.

https://linktr.ee/Ta2squidpodcast linktr.ee/thereisabetter… --- Support this podcast: https://podcasters.spotify.com/pod/show/ta2squidpodcast/support

Ovarian cancer, often referred to as the "silent killer," has been misunderstood for years. In this episode of 20-Minute Health Talk, Jill Whyte, MD, a leading gynecologic oncologist at Northwell Health, demystifies the subtle symptoms that frequently go unnoticed and emphasizes the critical role of early diagnosis — particularly for those at the highest risk of ovarian cancer. She also explores the latest advances in treatment, from targeted therapies like PARP inhibitors, to minimally invasive surgeries and new preventive strategies. Prophylactic fallopian tube removal has been the standard of care for those at the highest risk but is now being used in certain situations for women at average risk. During Ovarian Cancer Awareness Month in September, Dr. Whyte implores women everywhere to educate themselves and their family and friends to help reduce the impact of this deadly disease. Chapters: 01:15 - Ovarian cancer prevalence, trends 01:54 - Ovarian cancer symptoms 04:20 - PARP inhibitors and other ovarian cancer treatments 06:00 - Ovarian cancer risk factors 06:38 - Surgery types 08:38 - Strategies to prevent ovarian cancer 10:30 - The role of the fallopian tubes 14:50 - Catching ovarian cancer early 15:17 - Genetic testing 16:12 - Northwell's Cancer Institute 17:15 - Patient navigators Watch episodes of 20-Minute Health Talk on YouTube.  For information on our more than 100 medical specialties, visit Northwell.edu and follow us @NorthwellHealth on Facebook, Instagram, X and LinkedIn. Interested in a career at Northwell Health? Visit http://bit.ly/2Z7iHFL and explore our many opportunities.   Facebook –   / northwellhealth   Instagram -   / northwellhealth   X - https://www.x.com/northwellhealth LinkedIn - https://www.linkedin/northwellhealth  

Not seeing improvement on your current candida protocol?  You may find better results through natural remedies! In this episode, I'll name the most effective herbal supplements, recommended dosages, and the best lifestyle habits that will help to heal candida overgrowth. Watch now! Candida Diet Handout: https://drruscio.com/wp-content/uploads/2024/05/Candida-Diet-Handout-2024.pdf  

Prior to initiating the war of conquest of the land of Canaan, the nation did the prudent thing: they undertook a reconnaissance mission to scout out the enemy defenses. Moshe selected 12 righteous men, one from each tribe, to traverse the land and inspect it from the inside. The result was a catastrophic disaster: the […]

Prior to initiating the war of conquest of the land of Canaan, the nation did the prudent thing: they undertook a reconnaissance mission to scout out the enemy defenses. Moshe selected 12 righteous men, one from each tribe, to traverse the land and inspect it from the inside. The result was a catastrophic disaster: the scouts brought a devastating report about the land, prompting the people to lose faith in God and in the prospect of entering Canaan. In this Parsha podcast, we explore three elements of the Parsha: the first segment orients around one of the descriptions of the land offered by the scouts. The second and third segments relate to the end of the Parsha: The execution of a person who was gathering twigs on Shabbos, and the commandment to tie fringes to corners of our garments.– – – – – – – – – – – – – – – – – – – – – –DONATE to TORCH: Please consider supporting the podcasts by making a donation to help fund our Jewish outreach and educational efforts at https://www.torchweb.org/support.php. Thank you!– – – – – – – – – – – – – – – – – – – – – –Email me with questions, comments, and feedback: rabbiwolbe@gmail.com– – – – – – – – – – – – – – – – – – – – – –SUBSCRIBE to my Newsletterrabbiwolbe.com/newsletter– – – – – – – – – – – – – – – – – – – – – –SUBSCRIBE to Rabbi Yaakov Wolbe's PodcastsThe Parsha PodcastThe Jewish History PodcastThe Mitzvah Podcast This Jewish LifeThe Ethics PodcastTORAH 101 ★ Support this podcast ★

Attacks on reproductive freedom! Attacks on queer & trans folk! Attacks on books! It’s enough to make you want to scream into the void. Thankfully, there’s an alternative to screaming into the void that you might not have heard of yet—and solid action you can take. Let us introduce you to